Skip to product information
Vial labeled 'PRG Retatrutide' on a white background

Retatrutide (GLP-1R Agonist) – Advanced Research Peptide (20mg)

€180,00
Standard Vial or Pen Format ( RUO )

Retatrutide 20 mg (GLP-1/GIP/Glucagon Triple Agonist)Β Overview:

Developed by Eli Lilly, Retatrutide is designed to bind three critical metabolic receptors for enhanced therapeutic effect. Activating GLP‑1R improves insulin secretion and satiety, GIPR enhances insulin response and may promote healthy fat metabolism, while GCGR activation increases energy expenditure. As a next-generation peptide, Retatrutide represents a leap forward in metabolic pharmacotherapy.

Research

  • Weight Loss: Phase 2 trials demonstrated mean weight reductions of ~17.5% at 24 weeks, with up to 24.2% mean loss at 48 weeks in the highest dose group.Β 

  • Receptor Potency: In vitro, Retatrutide shows potent agonist activity with ECβ‚…β‚€s of ~0.0643β€―nM at GIPR, ~0.775β€―nM at GLP‑1R, and ~5.79β€―nM at GCGR.

  • The triple-receptor activation supports a combination of metabolic pathways: reducing appetite, improving glucose regulation, and boosting energy burn.Β 

Product Description

  • Synonyms: Retatrutide, LY‑3437943, GLP1‑R

  • Molecular Formula: C₂₂₃H₃₄₃F₃N₄₆O₇₀

  • Molecular Weight: ~4845β€―g/mol

  • CAS Number: 2381089‑83‑2Β 

  • Total Active Ingredient: 20 mg per vial

  • Shelf Life: 36 months

Product Usage

This item is supplied for research purposes only and is intended solely for in vitro studies and laboratory experiments. All information provided on this website is for educational use only. Any form of administration to humans or animals is strictly prohibited by law. This product must only be handled by licensed, qualified professionals. It is not a drug, food, or cosmetic, and must not be misrepresented, mislabeled, or used as such.

Peptide Storage

All information provided by Regenesis is for educational and informational purposes only. All Regenesis products are supplied for in-vitro research use onlyβ€”meaning experiments conducted outside of a living organism (β€œin glass”). These compounds are not medicines or drugs, have not been evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. Any administration to humans or animals is strictly prohibited by law.

Best Practices for Storing Peptides

To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.

  • Short-Term Storage (days to months): Keep peptides cool and protected from light. Temperatures below 4 Β°C (39 Β°F) are generally suitable. Lyophilized peptides often remain stable at room temperature for several weeks, but refrigeration is still preferred if use is not immediate.
  • Long-Term Storage (months to years): Store peptides at –80 Β°C (–112 Β°F) for maximum stability. Avoid frost-free freezers, as defrost cycles can cause damaging temperature fluctuations.
  • Minimize Freeze–Thaw Cycles: Repeated freezing and thawing accelerates degradation. Instead, divide peptides into aliquots before freezing.

Preventing Oxidation & Moisture Damage

Peptides can be compromised by exposure to moisture and airβ€”especially immediately after removal from a freezer.

  • Let the vial warm to room temperature before opening to prevent condensation.
  • Keep containers sealed as much as possible, and if possible, reseal under a dry, inert gas such as nitrogen or argon.
  • Amino acids like cysteine (C), methionine (M), and tryptophan (W) are particularly sensitive to oxidation.


Storing Peptides in Solution

Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.

  • If storage in solution is unavoidable, use sterile buffers at pH 5–6.
  • Prepare single-use aliquots to avoid repeated freeze–thaw cycles.
  • Most peptide solutions are stable for up to 30 days at 4 Β°C (39 Β°F), but sensitive sequences should remain frozen when not in use.


Containers for Peptide Storage

Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.

  • Glass vials: offer clarity, durability, and chemical resistance.
  • Plastic vials: polystyrene (clear but less resistant) or polypropylene (translucent but chemically resistant).
  • Peptides shipped in plastic vials may be transferred to glass for long-term storage if desired.


Regenesis Peptide Storage Quick Tips

  • Keep peptides in a cold, dry, dark environment
  • Avoid repeated freeze–thaw cycles
  • Minimize exposure to air
  • Protect from light
  • Avoid storing in solution long term
  • Aliquot peptides to match experimental needs

You may also like